Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2017

Sep 11, 2017

34117_dirs_2017-09-11_bfef1c7b-11a9-4ee6-9d39-4d3b6c85c04c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2016-08-23

Reporting Person: MONAHAN JOHN J (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (Right to Buy) $3.13 2026-08-23 Common Stock (6000) Direct

Footnotes

F1: Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.

F2: The option vests and becomes exercisable 50% on September 30, 2016 and 50% on December 31, 2016.

F3: This Form 3/A is being filed to correct a typo in the expiration date column to reflect that the Employee Stock Option expires on August 23, 2026, not August 23, 2016.